BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20532174)

  • 1. "Topological significance" analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response.
    Vellaichamy A; Dezso Z; JeBailey L; Chinnaiyan AM; Sreekumar A; Nesvizhskii AI; Omenn GS; Bugrim A
    PLoS One; 2010 Jun; 5(6):e10936. PubMed ID: 20532174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
    Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
    Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
    Bisoffi M; Klima I; Gresko E; Durfee PN; Hines WC; Griffith JK; Studer UE; Thalmann GN
    J Urol; 2004 Sep; 172(3):1145-50. PubMed ID: 15311059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen.
    Coutinho-Camillo CM; Salaorni S; Sarkis AS; Nagai MA
    Cancer Genet Cytogenet; 2006 Apr; 166(2):130-8. PubMed ID: 16631469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.
    Saraon P; Musrap N; Cretu D; Karagiannis GS; Batruch I; Smith C; Drabovich AP; Trudel D; van der Kwast T; Morrissey C; Jarvi KA; Diamandis EP
    J Biol Chem; 2012 Oct; 287(41):34019-31. PubMed ID: 22908226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.
    D'Antonio JM; Ma C; Monzon FA; Pflug BR
    Prostate; 2008 May; 68(7):698-714. PubMed ID: 18302219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
    Giménez-Bonafé P; Fedoruk MN; Whitmore TG; Akbari M; Ralph JL; Ettinger S; Gleave ME; Nelson CC
    Prostate; 2004 May; 59(3):337-49. PubMed ID: 15042610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems.
    Tasseff R; Nayak S; Salim S; Kaushik P; Rizvi N; Varner JD
    PLoS One; 2010 Jan; 5(1):e8864. PubMed ID: 20126616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
    Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells.
    Katta S; Srivastava A; Thangapazham RL; Rosner IL; Cullen J; Li H; Sharad S
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells.
    Tu LC; Yan X; Hood L; Lin B
    Mol Cell Proteomics; 2007 Apr; 6(4):575-88. PubMed ID: 17220478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular alterations associated with LNCaP cell progression to androgen independence.
    Shi XB; Ma AH; Tepper CG; Xia L; Gregg JP; Gandour-Edwards R; Mack PC; Kung HJ; deVere White RW
    Prostate; 2004 Aug; 60(3):257-71. PubMed ID: 15176055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network analysis of an in vitro model of androgen-resistance in prostate cancer.
    Detchokul S; Elangovan A; Crampin EJ; Davis MJ; Frauman AG
    BMC Cancer; 2015 Nov; 15():883. PubMed ID: 26553226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independence of HIF1a and androgen signaling pathways in prostate cancer.
    Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
    BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
    Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
    Oosterhoff JK; Grootegoed JA; Blok LJ
    Endocr Relat Cancer; 2005 Mar; 12(1):135-48. PubMed ID: 15788645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells.
    Karan D; Kelly DL; Rizzino A; Lin MF; Batra SK
    Carcinogenesis; 2002 Jun; 23(6):967-75. PubMed ID: 12082018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.